Ascentage Pharma Olverembatinib
LOCUST WALK NEWS Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib Ascentage Pharma […]
News
2024
Locust Walk Webinar
Align Summit
Align Summit 2024 Align Summit – April 25, 2024 Locust Walk proudly partnered with MassBio and McKinsey & Co. for
Locust Walk Webinar
Locust Walk RNA Innovation Conference – May 9th, 2023
Loucst Walk RNA Innovation Conference in partnership with Dr. Frank Slack, Director of the Harvard Medical School Initiative for RNA
Locust Walk Webinar
Locust Walk Stem Cell Tx Conference in partnership with Harvard Stem Cell Institute – April 11th, 2022
Locust Walk Stem Cell Tx Conference in partnership with Harvard Stem Cell Institute April 11th, 2022, Conference in Review We
Podcast
Biotalk Episode 16: A Conversation with Stephen Sands of Lazard
Podcast: Play in new window | Download (Duration: 33:54 — 77.6MB)
Subscribe: Apple Podcasts | Spotify | RSS
On this episode of Biotalk, Locust Walk’s Geoff Meyerson welcomes Stephen Sands, former Vice Chairman of Investment Banking and Chairman of the Global
Uncategorized
Rapid micro
Transaction Case Studies MULTI-TRACK ENGAGEMENT LEADING TO AN EQUITY INVESTMENT Situation Assessment Rapid Micro Biosystems is a privately held, commercial
Uncategorized
Chimerix symbio case study
Transaction Case Studies GLOBAL DEAL WITH A JAPANESE COMPANY FOR BRINCIDOFOVIR, A BROAD-SPECTRUM ANTIVIRAL FOR THE TREATMENT AND PREVENTION OF
Uncategorized
Anokion and kanyos
Transaction Case Studies RAPID M&A ADVISORY Situation Assessment Anokion Bio is Swiss biotechnology company focused on autoimmune diseases by restoring
Uncategorized
Xyphos case study
Transaction Case Studies MULTI-TRACK ENGAGEMENT LEADING TO ACQUISITION OF XYPHOS BY ASTELLAS FOR $120M UPFRONT AND $545M IN MILESTONE PAYMENTS
Uncategorized
Targovas iovaxis case study
Transaction Case Studies SELL-SIDE ENGAGEMENT LEADING TO OPTION AGREEMENT FOR GREATER CHINESE RIGHTS TO A RAS PEPTIDE CANCER VACCINE Situation